Dietary enrichment with n-3 lc-PUFA-rich fish oil improves preclinical outcome of radiotherapy and anti-PD-L1 combination treatment
A modest reduction in the risk of local tumor failure was observed upon n-3 lc-PUFA-rich fish oil administration, highlighting a need for further research.
Authors
- Ardy van Helvoort (ORCID: https://orcid.org/0000-0002-3585-0676)
- Lara M. Stoffels (ORCID: https://orcid.org/0000-0002-0418-7293)
- Lesley Schuitmaker (ORCID: https://orcid.org/0000-0001-9170-6380)
- Èlia Prades-Sagarra (ORCID: https://orcid.org/0000-0003-2834-967X)
- Annemarie J. F. Westheim
- Ala Yaromina (ORCID: https://orcid.org/0000-0002-3900-5314)
- Jan Theys (ORCID: https://orcid.org/0000-0002-9718-8251)
- RAMON C. J. LANGEN (ORCID: https://orcid.org/0000-0002-8622-3058)
- Ludwig J. Dubois (ORCID: https://orcid.org/0000-0002-8887-4137)
- Jeroen van Bergenhenegouwen (ORCID: https://orcid.org/0000-0001-8517-4904)
- Hester van Mourik (ORCID: https://orcid.org/0000-0003-2044-4285)
- Ronit Shiri‐Sverdlov (ORCID: https://orcid.org/0000-0002-6736-7814)
- Miriam van Dijk
- Jella G M van de Laak
Institutions
- Maastricht University Medical Centre (NL)
- Maastricht University (NL)
- Danone (Netherlands) (NL)
- Nutricia Research (Netherlands) (NL)
- Maastro Clinic (NL)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ctarc.2025.100943
- Citations
- 2
- Primary Topic
- Cancer, Stress, Anesthesia, and Immune Response
- Type
- article
- Field-Weighted Citation Impact
- 2.94